Cooperation agreement with Intermed Discovery
c-LEcta closes a cooperation agreement with Intermed Discovery from Dortmund. Intermed Discovery, which is a management buy out from Bayer, owns complex collections of compounds and micro-organisms with large genetic biodiversity. Based on the long-time experience of Intermed Discovery a special part of that genetic pool was selected and processed for the identification of new enzymes by c LEcta. With its proprietary screening platform c-LEcta will identify and market new innovative enzymes in the provided biodiversity.